Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking
- 15 June 2004
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 93 (12), 1469-1472
- https://doi.org/10.1016/j.amjcard.2004.03.005
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: One-year resultsJournal of the American College of Cardiology, 2004
- Atherosclerosis: The Road AheadCell, 2001
- Increased Platelet Aggregability Associated With Platelet
GPIIIa Pl
A2 Polymorphism Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Integrins and vascular extracellular matrix assembly.JCI Insight, 1997
- PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosisThe Lancet, 1997
- Platelets and Coronary Artery DiseaseThe New England Journal of Medicine, 1996
- Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular MedicineThe New England Journal of Medicine, 1995
- Function and Regulation of the β3 Integrins in Hemostasis and Vascular BiologyThrombosis and Haemostasis, 1995
- Vascular EndotheliumAnnals of the New York Academy of Sciences, 1994
- The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.JCI Insight, 1989